APOPTOSIS AND A REINVESTIGATION OF THE BIOLOGIC BASIS FOR CANCER-THERAPY

作者：DAMICO **^*; MCKENNA WG

来源：Radiotherapy and Oncology, 1994, 33(1): 3-10.

DOI：10.1016/0167-8140(94)90079-5

• APOPTOSIS
• CANCER THERAPY
• BCL-2
• ANTISENSE THERAPY
• SURAMIN

Antitumor therapy has expanded beyond the previous notions of cytotoxic or biologic therapy to now include agents that induce differentiation (e.g. ail trans-retinoic acid for induction of complete remission in patients with acute promyelocytic leukemia [23]) or apoptosis [91]. In fact, the phenomenon of apoptosis may be fundamental to the current understanding of carcinogenesis [11] and may also underlie the effectiveness of some forms of chemotherapy [4,5,18,39,56,59,67], radiation therapy [19,44,52,60,64,77,78,85] and the interferons [73]. The process of apoptosis has been shown to be responsible for the normal elimination of cells with damaged DNA [81] as well as other potentially dangerous cells such as autoreactive T-lymphocytes [14]. Therefore, although much attention has been given to oncogenes that induce cellular proliferation, one can easily see how the same result (i.e. neoplasia) could be obtained when the ability of a cell to undergo apoptosis is lost.

• 出版日期1994-10